Medical Devices Market Report

  Artificial insemination Market Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country. Global  Artificial Insemination Market  is expected to register a  CAGR of 8.56%  during the forecast period and is expected to hit  USD 3,409.75 Million by 2027 . The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycles of ART in wo...

  COVID Testing Kit Market According to the latest data, there were 86,827 new cases on 16 May 2020 and 7,215,102 new cases on 8 June 2020, globally. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth. Global  COVID Testing Kit Market  is expected to have a market value of  USD 97,903.2 Million  by 2027. Major Key Players: MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biotech Co., Lt...

  Dental Consumables Market Dental Consumables are a category of products that are used on patients by dental practioners to treat prevent, restore, diagnosis and emergency oral health issues. Dental consumables industry has thus flourished as a result of many factors such as rising expenditure on healthcare, increasing income, technological advancements in products etc. According to Market Research Future's expert market report, the global  dental consumables market  is set to grow at a CAGR of 6.5% during the forecast period Dental procedures are not just restricted to repairing or treating of dental diseases, another niche market in the dental industry is the cosmetic dentistry market, which is growing at a steady rate due to the reasons concerned with enhancing of the overall facial beauty among the masses and increased disposable incomes. Irregularities or dissatisfaction with the appearance of the mouth and the oral cavity can lead to a visit for the cosmetic dentis...

  CBD Market As per CBD market analysts, the global market is anticipated to witness growth owing to the factors such as the growing research & development as well as financial support by various private and government organizations. However, the market will face challenges and restraints due to adverse effects associated with cannabis and stringent government policies during the forecast period. The global  CBD market  will grow at a  CAGR of 125.58%  during the forecast period. The market for CBD is set to reach US$22,07,162.54 million by 2026. Rising occurrence of chronic diseases in the CBD market will support the growth. As per market analysts, the market-based companies will face certain challenges during the forecast period 2019 to 2026. The market research report provides in-depth analysis of the application, end user, forms, product, routes of administration, and source segments. The market research report presents factors such as complications rega...

  Viral Vector Manufacturing Market Viral vector manufacturing refers to the production of a carrier called a vector which is genetically engineered to deliver the gene because they can deliver the new gene by infecting the cell.  Considered as a drug substance, viral vectors are used in gene therapy and vaccinology (vaccines). In the case of cell therapies, the scrutiny for testing for adventitious agents is high. Viruses that are often used as vectors include retroviruses that integrate their genetic material including the new gene in the human cell, and adenoviruses, that introduce their DNA into the nucleus of the cell without letting the DNA to integrate into a chromosome. These viruses are modified so they can't cause disease when used in people. Gene therapy has seen various clinical advancement, and along with it, the viral vector manufacturing market is growing pervasively. Gene therapy is one of the most preferred treatment options for a number of chronic diseases. O...

  Healthcare Cloud Computing Market The volume of digital data in healthcare centers has multiplied over the years owing to changes in payment modes, increasing patient pool, etc.  Advances in technology and increasing healthcare expenditure have further catalyzed the growth of the market.  The Global  Healthcare Cloud Computing Market  is experiencing increasing traction owing to the rising uptake of cloud computing in small, medium, and large healthcare setups, worldwide. The need for the deployment of cloud computing and cutting-edge analytical tools has intensified, enhancing operational efficiency. These factors subsequently escalate the market on the global platform. According to Market Research Future (MRFR), the global healthcare cloud computing market is expected to expand exponentially by 2023. In its recently published analysis, MRFR also asserts that during the forecast period (2018 – 2023) the market would register a phenomenal CAGR. The market valu...

  Remdesivir Market Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19 )  market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19 ) , are expected to restrain the growth of the global Remdesivir (COVID 19 )  market. According to MRFR analysis, Global  Remdesivir (COVID 19) Market  is expected to register a  CAGR of 31.2%  during the forecast period of 2020 to 2027 and reach  USD 10,119.99 Million by 2027. Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfiz...

  Cardiac Biomarkers Market The key factors that drive the cardiac biomarkers market are the increasing prevalence of cardiovascular diseases and lifestyle diseases, increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment & research in which cardiac biomarkers are used, technological advancements in cardiac biomarkers, and favorable government initiatives to create awareness related to cardiovascular diseases. However, a lack of awareness among people is expected to hamper market growth. The global  cardiac biomarkers market  is expected to register a  CAGR of 16.36%  during the forecast period and is expected to hit  USD 4236.02 Million by 2027 . There are a number of factors that impact the growth of the cardiac biomarkers market. Some of the key factors include a rise in demand for diagnostic and testing of various cardiovascular diseases, development and adva...

  Healthcare Cyber Security Market Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime. Healthcare Cyber Security Market  is expected to register a  CAGR of   11.82%  during the forecast period, with a market value of  USD 16,393.15 Million till 2025. The primary vital factors driving the market growth are the increasing cyberattacks in the healthcare industry, regulatory and government norms to protect patient data, and the growing implementation of mobile device applications and platforms and increased use of Internet of things (IoT) devices in the healthcare sector. However, factors such as lack of ado...

  Uveitis Treatment Market Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis. The growth of the global uveitis treatment market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period. According to MRFR analysis,  Uveitis Treatment Market   is expected to register a  CAGR of 5.6%  during the forecast period and was valued at  USD 534.6 million in 2018 . The global uveitis treatment market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collaborations to st...

  Gene Therapy Market Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. According to MRFR analysis, the global  gene therapy market  is expected to register a  CAGR of 40.7%  during the forecast period and was valued at USD 524 million in 2018. The growth of the global gene therapy market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global gene therapy market. The global gene therapy market is currently dominated b...

  Insulin Pumps Market The market for insulin pumps is set to reach US$8,520.9 million by 2023. The global market is anticipated to witness growth owing to the factors such as growing prevalence of diabetes as well as the increasing awareness about the disease . However, the market will face challenges and restraints due to expenses associated with insulin and the rise in insulin cost during the forecast period. The global  Insulin Pumps Market , during the forecast period, will register growth at a  CAGR of 8.4%. The growing development activities in the market is set to play a key role in determining the growth potential during forecast year. Analysts have also studied the market to understand potential threats and challenges the insulin pumps market companies could face. Although the market is poised to grow at a fast pace across type, accessories, end-users, and applications segments, factors such as the growing inclination towards naturopathy could slow down the...

  Cystic Fibrosis Therapeutics Market Cystic fibrosis is a genetic disease that impacts the entire body turning on disability and causing death at an early age in many cases. It is mainly caused by mutations in the gene encoded as cystic fibrosis transmembrane conductance regulator (CFTR) protein. The report further encompasses segmental analysis, studies factors that can have far-reaching impacts, and introduces expert opinions to provide a comprehensive understanding of the market. The  cystic fibrosis market  is witnessing exponential growth as the investment in the field for further drug development is increasing. Increasing investment in the research and development for better drugs and therapies can take the cystic fibrosis market forward. At the same time, the Cystic Fibrosis Foundation (CFF) is spending in millions to aid the healthcare system. In the U.S., CFF has invested USD 425 million for the drug development of this particular disease which in itself is an a...